<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="Letters to the Editor Why we should not stop giving" exact="aspirin" post="to pregnant women during the COVIDâ€�19 pandemic Aspirin, pregnancy"/>
 <result pre="been made in a small group of young people taking" exact="ibuprofen" post="for COVIDâ€�19 symptoms3, 4. As a result, French health"/>
 <result pre="of Health has stated that there is no evidence that" exact="ibuprofen" post="(or other NSAIDs) could worsen SARSâ€�CoVâ€�2 infection. However, it"/>
 <result pre="other NSAIDs) could worsen SARSâ€�CoVâ€�2 infection. However, it stated that" exact="ibuprofen" post="might mask the symptoms of infection, therefore delaying diagnosis6."/>
 <result pre="cause for concern regarding the wellbeing of pregnant women taking" exact="aspirin" post="for prophylaxis of preâ€�eclampsia and fetal growth restriction. The"/>
 <result pre="professionals and pregnant women, leading to withdrawal of prophylactic lowâ€�dose" exact="aspirin" post="therapy. Currently, there are no available data regarding the"/>
 <result pre="pregnant women in the series of Schwartz was severe11. Lowâ€�dose" exact="aspirin" post="has been proven to be an effective regimen for"/>
 <result pre="pregnancy, including preâ€�eclampsia and fetal growth restriction. Intake of lowâ€�dose" exact="aspirin" post="during pregnancy is not associated with an increased risk"/>
 <result pre="of the ductus arteriosus8. The recommended dosage of 150â€‰mg of" exact="aspirin" post="daily for the prevention of preâ€�eclampsia is based on"/>
 <result pre="preterm preâ€�eclampsia occurred in 1.6% of women in the lowâ€�dose" exact="aspirin" post="group, as compared with 4.3% in the placebo group"/>
 <result pre="an official statement recommending not to avoid the use of" exact="ibuprofen" post="based on the current available data12. To our knowledge,"/>
 <result pre="that there is an association between prophylactic use of lowâ€�dose" exact="aspirin" post="and increased risk of progression of SARSâ€�CoVâ€�2 infection. In"/>
 <result pre="provide firstâ€�trimester screening for placental complications and to prescribe lowâ€�dose" exact="aspirin" post="in women who are identified as high risk for"/>
 <result pre="risks of adverse outcome related to the usage of lowâ€�dose" exact="aspirin" post="in patients with SARSâ€�CoVâ€�2 infection. References References 1SchwartzDA, GrahamAL."/>
 <result pre="and delivery: rapid review. Ultrasound Obstet Gynecol2020; 55: 586â€&quot;592.32180292 3DayM.Covidâ€�19:" exact="ibuprofen" post="should not be used for managing symptoms, say doctors"/>
 <result pre="Lab Med2020 DOI: 10.5858/arpa.2020-0901-SA. 12Updated: WHO Now Doesn't Recommend Avoiding" exact="Ibuprofen" post="For COVIDâ€�19 Symptoms. https://www.sciencealert.com/who-recommends-to-avoid-taking-ibuprofen-for-covid-19-symptoms [Accessed 23 March 2020]"/>
</results>
